Imidazole antifungals are the conventional first choice for candidal balanoposthitis, but they are not always appropriate. When resistance to standard antifungal treatment is clinically suspected, or when the patient has a documented allergy to imidazoles, an alternative topical agent is needed.
This protocol targets candidal balanoposthitis in the setting of suspected antifungal resistance or allergy to imidazoles — circumstances in which imidazole-based topical therapy is either contraindicated or expected to be ineffective.
The protocol calls for a topical application of nystatin cream — an alternative to imidazole preparations suited to this specific scenario. The full regimen, including strength, frequency, and duration, is set out in the structured protocol below.
DOI: 10.1111/jdv.18954